Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration

PURPOSE: To evaluate the results of intravitreal expansile gas injection, with or without recombinant tissue plasminogen activator (rtPA), followed by intravitreal bevacizumab injection for treatment of submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (AMD). METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Nourinia, Ramin, Bonyadi, Mohammad Hossein Jabbarpour, Ahmadieh, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ophthalmic Research Center 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379921/
https://www.ncbi.nlm.nih.gov/pubmed/22737352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379921/
https://www.ncbi.nlm.nih.gov/pubmed/22737352

Ejemplares similares